Monnet, I <br/><br/>
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jan 2002 
 - 103-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdf006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Organoplatinum Compounds--adverse effects<br/>Oxaliplatin<br/>Survival Rate<br/>Vinblastine--adverse effects<br/>Vinorelbine